Invariant chain made in Escherichia coli has an exposed N-terminal segment that blocks antigen binding to HLA-DR1 and a trimeric C-terminal segment that binds empty HLA-DR1.
- 21 November 1995
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 92 (24) , 11289-11293
- https://doi.org/10.1073/pnas.92.24.11289
Abstract
Invariant chain (Ii), a membrane glycoprotein, binds class II major histocompatibility complex (MHC) glycoproteins, probably via its class II-associated Ii peptide (CLIP) segment, and escorts them toward antigen-containing endosomal compartments. We find that a soluble, trimeric ectodomain of Ii expressed and purified from Escherichia coli blocks peptide binding to soluble HLA-DR1. Proteolysis indicates that Ii contains two structural domains. The C-terminal two-thirds forms an alpha-helical domain that trimerizes and interacts with empty HLA-DR1 molecules, augmenting rather than blocking peptide binding. The N-terminal one-third, which inhibits peptide binding, is proteolytically susceptible over its entire length. In the trimer, the N-terminal domains act independently with each CLIP segment exposed and free to bind an MHC class II molecule, while the C-terminal domains act as a trimeric unit.Keywords
This publication has 36 references indexed in Scilit:
- Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression.The Journal of Experimental Medicine, 1993
- Mice lacking the MHC class II-associated invariant chainCell, 1993
- Stabilization of alpha-helical structures in short peptides via end capping.Proceedings of the National Academy of Sciences, 1993
- HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain negative cells.The Journal of Experimental Medicine, 1992
- MHC class II deletion mutant expresses normal levels of transgene encoded class II molecules that have abnormal conformation and impaired antigen presentation ability.The Journal of Immunology, 1992
- Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in sizeNature, 1992
- HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.Proceedings of the National Academy of Sciences, 1992
- The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptideCell, 1992
- Cathepsin B cleavage of Ii from class II MHC alpha- and beta-chains.The Journal of Immunology, 1991
- Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartmentsNature, 1991